|
2021
|
Invention
|
Immune modulation with tlr9 agonists for cancer treatment.
The present invention relates to meth... |
|
|
Invention
|
Use of a tlr9 agonist in methods for treating covid-19.
The present invention is directed to use... |
|
|
Invention
|
Use of a tlr9 agonist in methods for treating covid-19. The present invention is directed to use ... |
|
2020
|
Invention
|
Immune modulation with tlr9 agonists for cancer treatment. The present invention relates to metho... |
|
2019
|
Invention
|
Treatment of cancer using tlr9 agonist with checkpoint inhibitors.
The invention provides method... |
|
|
Invention
|
Tlr9 modulators for treating cancer.
The present disclosure relates to methods for treating canc... |
|
|
Invention
|
Tlr9 modulators for treating cancer. The present disclosure relates to methods for treating cance... |
|
|
G/S
|
Medical therapeutic preparations, namely, biologically active modulators, biologically active imm... |
|
2017
|
Invention
|
Compositions for inhibiting checkpoint gene expression and uses thereof.
The present invention i... |
|
|
Invention
|
Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune res... |
|
|
Invention
|
Toll-like receptor 9 antagonist and methods of use thereof.
The invention provides antagonist of... |
|
|
Invention
|
Compositions and methods for inhibiting target rna expression. The present invention relates to t... |
|
|
Invention
|
Potentiation of mmrna therapeutics. The present invention relates to the use of immune regulatory... |
|
2016
|
Invention
|
Compositions for inhibiting nlrp3 gene expression and uses thereof.
The present invention is dir... |
|
|
Invention
|
Compositions for inhibiting nlrp3 gene expression and uses thereof. The present invention is dire... |
|
|
Invention
|
Compositions for inhibiting dux4 gene expression and uses thereof.
The present invention is dire... |
|
|
Invention
|
Compositions for inhibiting dux4 gene expression and uses thereof. The present invention is direc... |
|
|
Invention
|
Compositions for inhibiting checkpoint gene expression and uses thereof. The present invention is... |
|
|
Invention
|
Toll-like receptor 9 antagonist and methods of use thereof. The invention provides antagonist of ... |
|
|
G/S
|
Medical therapeutic preparations, namely, nucleic acids as biologically active modulators, nuclei... |
|
2015
|
Invention
|
Treatment of cancer using tlr9 agonist with checkpoint inhibitors. The invention provides methods... |
|
2014
|
Invention
|
Compositions for inhibiting gene expression and uses thereof.
The inventors have examined the me... |
|
|
Invention
|
Stabilized immune modulatory rna (simra) compounds for tlr7 and tlr8. The invention relates to th... |
|
2012
|
Invention
|
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modifi... |
|
|
Invention
|
Stabilized immune modulatory rna (simra) compounds. The invention relates to the therapeutic use ... |
|
2011
|
Invention
|
Stabilized immunomodulatory oligonucleotides. The invention provides immunostimulatory oligonucle... |
|
|
Invention
|
Compositions for inhibiting gene expression and uses thereof. The inventors have examined the mea... |
|
|
Invention
|
Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents.
Th... |
|
2005
|
G/S
|
Reagents for the detection of polymerase chain reactions for scientific or research use; diagnost... |
|
|
G/S
|
Reagents for the detection of polymerase chain reactions for
scientific or research use; diagnos... |
|
|
G/S
|
Medical and scientific research in the area of oligonucleotides or chemical products; pharmaceuti... |
|
2003
|
G/S
|
immunomodulatory oligonucleotides, namely, ingredients that enhance or induce an immune response ... |
